Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$110.08 - $142.92 $6.18 Million - $8.02 Million
56,100 Added 86.71%
120,800 $14.3 Million
Q4 2021

Feb 15, 2022

SELL
$99.73 - $148.48 $8.58 Million - $12.8 Million
-86,000 Reduced 57.07%
64,700 $8.92 Million
Q3 2021

Nov 16, 2021

BUY
$98.85 - $138.91 $12.5 Million - $17.5 Million
126,000 Added 510.12%
150,700 $20.9 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $894,608 - $1.43 Million
13,600 Added 122.52%
24,700 $2.4 Million
Q1 2021

May 18, 2021

SELL
$64.07 - $91.75 $1.61 Million - $2.31 Million
-25,200 Reduced 69.42%
11,100 $759,000
Q4 2020

Feb 17, 2021

BUY
$65.07 - $98.24 $1.55 Million - $2.34 Million
23,800 Added 190.4%
36,300 $3.11 Million
Q3 2020

Nov 17, 2020

SELL
$59.04 - $77.95 $6.65 Million - $8.78 Million
-112,600 Reduced 90.01%
12,500 $813,000
Q2 2020

Aug 17, 2020

BUY
$29.01 - $74.23 $1.82 Million - $4.65 Million
62,600 Added 100.16%
125,100 $9.15 Million
Q1 2020

May 15, 2020

BUY
$27.51 - $57.29 $1.48 Million - $3.08 Million
53,800 Added 618.39%
62,500 $2.13 Million
Q4 2019

Feb 14, 2020

SELL
$40.86 - $57.65 $837,630 - $1.18 Million
-20,500 Reduced 70.21%
8,700 $474,000
Q3 2019

Nov 14, 2019

BUY
$37.38 - $49.47 $1.09 Million - $1.44 Million
29,200 New
29,200 $1.22 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.